Table 4. Comparison of MSKCC and Heng's Model and their modified models.

	MSKCC Model				Post-treatment Eosinophil modified MSKCC Model
	Patients (No.)	1-Year Survival	2-Year Survival	Median Survival	Patients (No.)	1-Year Survival	2-Year Survival	Median Survival	p-value
Favorable	66	91.40%	77.60%	77.9 months	99	93.70%	76.20%	77.9 months	0.756
Intermediate	178	77.30%	48.80%	22.4 months	140	70.20%	38.60%	19.4 months	0.121
Poor	38	25.10%	0.00%	8.9 months	33	22.60%	0.00%	8.8 months	0.787
	Heng's Model				Post-treatment Eosinophil modified Heng's Model
	Patients (No.)	1-Year Survival	2-Year Survival	Median Survival	Patients (No.)	1-Year Survival	2-Year Survival	Median Survival	p-value
Favorable	55	86.60%	75.70%	77.9 months	96	92.90%	78.20%	77.9 months	0.712
Intermediate	158	82.20%	55.20%	31.1 months	126	77.50%	44.70%	21.9 months	0.098
Poor	69	41.30%	13.70%	10.3 months	60	35.70%	11.00%	9.4 months	0.707